Evidence map›Paper›PMID 35506823›Full record

ArticleEuropean journal of clinical investigation2022

Interferon lambda 3 in the early phase of coronavirus disease-19 can predict oxygen requirement.

Tetsuya Suzuki, Noriko Iwamoto, Shinya Tsuzuki, Yuko Kakumoto, Michiyo Suzuki, Shinobu Ashida, Yusuke Oshiro, Takeshi Nemoto, Kohei Kanda, Ayako Okuhama and 13 more

Abstract readLetter
In one paragraph

Article in European journal of clinical investigation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. IFN Lambda Deficiency Contributes to Severe COVID-19 Outcomes.International journal of molecular sciences · 2024
    Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Tetsuya SuzukiDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.ORCID 0000-0003-3165-9062
Noriko IwamotoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shinya TsuzukiDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yuko KakumotoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Michiyo SuzukiDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shinobu AshidaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yusuke OshiroClinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan.
Takeshi NemotoClinical Laboratory Department, National Center for Global Health and Medicine, Tokyo, Japan.
Kohei KandaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Ayako OkuhamaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Gen YamadaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Makoto InadaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Lubna SatoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yusuke MiyazatoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Yutaro AkiyamaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Sho SaitoDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Shinichiro MoriokaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Mugen UjiieDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Kayoko HayakawaDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.
Masaya SugiyamaGenome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Ichikawa, Japan.
Masashi MizokamiGenome Medical Sciences Project, Research Institute, National Center for Global Health and Medicine, Ichikawa, Japan.
Eiichi N KodamaDepartment of Infectious Disease, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
Norio OhmagariDisease Control and Prevention Center, National Center for Global Health and Medicine, Tokyo, Japan.

Funding

Japan Agency for Medical Research and Development 20fk0108412h0001National Center for Global Health and Medicine 21A1007
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansInterferon LambdaInterferonsInterleukinsOxygenVirus ReplicationInterferon Lambdainterferon-lambda, humanInterferonsInterleukinsOxygen

Identifiers

PMID35506823
PMCPMC9541409

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.